hHER2*ex20ins-IRES-Luc-2A-EGFP
品系基本信息
驗(yàn)證數(shù)據(jù)
Fig1. The genotype of hHER2*ex20ins-IRES-Luc-2A-EGFP cell was identified by PCR
WT: wild-type cells; H2O: negative water control; 100bp DNA marker from Transgen (BM311)
Fig2. Tumor growth curve?in hHER2*ex20ins-IRES-Luc-2A-EGFP?subcutaneously transplanted tumor model (n=9)??
Fig3. Body weight change in hHER2*ex20ins-IRES-Luc-2A-EGFP subcutaneously transplanted tumor model?(n=9)
Fig4. Bioluminescence imaging of hHER2*ex20ins-IRES-Luc-2A-EGFP subcutaneously?transplanted tumor model at the end of timepoint
你也可能感興趣
Cre-ERT2在無(wú)Tamoxifen誘導(dǎo)的情況下，在細(xì)胞質(zhì)內(nèi)處于無(wú)活性狀態(tài)；當(dāng)Tamoxifen誘導(dǎo)后，Tamoxifen的代謝產(chǎn)物4-OHT（雌激素類似物）與ERT結(jié)合，可使Cre-ERT2進(jìn)核發(fā)揮Cre重組酶活性。
查看常見(jiàn)的基因工程小鼠可以分為兩種命名方式，包括基因定點(diǎn)修飾的小鼠命名，比如：敲除、敲入、點(diǎn)突變等等，和隨機(jī)轉(zhuǎn)基因的小鼠命名。
查看
